No increased risk of anaphylaxis with AstraZeneca COVID-19 vaccine

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2021年 / 1849卷 / 1期

关键词：

D O I：

10.1007/s40278-021-93387-2

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：3 / 3

相关论文

共 50 条

[31] Amyotrophic neuralgia secondary to Vaxzevria (AstraZeneca) COVID-19 vaccine
Crespo Burillo, J. A.
Loriente Martinez, C.
Garcia Arguedas, C.
Mora Pueyoa, F. J.
NEUROLOGIA, 2021, 36 (07): : 571 - 572
[32] VACCINES AstraZeneca's COVID-19 vaccine woes mount
Cross, Ryan
CHEMICAL & ENGINEERING NEWS, 2021, 99 (11) : 9 - 9
[33] Long-term safety of AstraZeneca COVID-19 vaccine
Reactions Weekly, 2023, 1956 (1) : 10 - 10
[34] COVID-19 and autoimmune phenomena: Vitiligo after Astrazeneca vaccine
Lopez Riquelme, Irene
Fernandez Ballesteros, Maria Dolores
Serrano Ordonez, Ana
Godoy Diaz, Daniel Jesus
DERMATOLOGIC THERAPY, 2022, 35 (07)
[35] AstraZeneca COVID-19 vaccine: thrombosis with thrombocytopenia case fatalities
Reactions Weekly, 2022, 1919 (1) : 7 - 7
[36] Adolescents with ADHD are at increased risk for COVID-19 vaccine hesitancy
Dvorsky, Melissa R.
Breaux, Rosanna
Langberg, Joshua M.
Becker, Stephen P.
JOURNAL OF PSYCHIATRIC RESEARCH, 2022, 152 : 25 - 30
[37] Pfizer-BioNTech COVID-19 vaccine-related risk of anaphylaxis
Reactions Weekly, 2021, 1838 (1) : 7 - 7
[38] Covid-19: AstraZeneca vaccine linked with small risk of ITP, real world data show
Wise, Jacqui
BMJ-BRITISH MEDICAL JOURNAL, 2021, 373 : n1489
[39] AstraZeneca's covid-19 (mis)adventure and the future of vaccine equity
Fortner, Robert
BMJ-BRITISH MEDICAL JOURNAL, 2022, 379
[40] Covid-19: Germany struggles with slow uptake of Oxford AstraZeneca vaccine
Boytchev, Hristio
BMJ-BRITISH MEDICAL JOURNAL, 2021, 372 : n619

← 1 2 3 4 5 →